Which chemo drug works best for esophageal cancer? new study has answers
NCT ID NCT07549269
First seen May 13, 2026 · Last updated May 14, 2026 · Updated 1 time
Summary
This study looked at 387 people with esophageal cancer to compare two chemotherapy drugs, nab-paclitaxel and paclitaxel, when used with immunotherapy before surgery. The goal was to see which drug helps more tumors disappear or shrink. Results can help doctors choose the better treatment option.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
West China Hospital
Chengdu, Sichuan, China
Conditions
Explore the condition pages connected to this study.